In conclusion, our findings using in silico analyses and in vitro model systems of HPV+ dysplasias and cancers uncovered gene alterations correlated with cervical cancer progression and regulated by NFX1-123 and HPV16 E6 and E7. The gene discussed is NFX1; the disease is cervical cancer.